Spero Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.42

+0.12 (+5.22%)

As of Feb 8, 2:09 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,195.0% upside

Low Target $21.51

Average Target $31.34

High Target $48.77

Current Price $2.42

Current
$2.42

Target
$31.34

$21.51 $31.34 avg $48.77

Scenario Analysis

Bear Case

$21.51

788.8%

Low target

Base Case

$31.34

+1,195.0%

Avg target

Bull Case

$48.77

+1,915.3%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$32.18

-92.5% from high

52-Week Low

$17.76

+-86.4% from low

Target vs 52W High

$31.34

-2.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%